Your browser doesn't support javascript.
loading
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer.
Rosenberg, Shoshana M; Zheng, Yue; Gelber, Shari; Ruddy, Kathryn J; Poorvu, Philip; Sella, Tal; Tamimi, Rulla M; Wassermann, Johanna; Schapira, Lidia; Borges, Virginia F; Come, Steven; Peppercorn, Jeffrey; Sepucha, Karen R; Partridge, Ann H.
Affiliation
  • Rosenberg SM; Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67St LA-0005, New York, NY, 10065, USA. shr4009@med.cornell.edu.
  • Zheng Y; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. shr4009@med.cornell.edu.
  • Gelber S; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. shr4009@med.cornell.edu.
  • Ruddy KJ; Harvard Medical School, Boston, MA, USA. shr4009@med.cornell.edu.
  • Poorvu P; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sella T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tamimi RM; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Wassermann J; Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Schapira L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Borges VF; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Come S; Harvard Medical School, Boston, MA, USA.
  • Peppercorn J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sepucha KR; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Partridge AH; Harvard Medical School, Boston, MA, USA.
Breast Cancer Res Treat ; 197(3): 547-558, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36436128

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Cancer Survivors Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Cancer Survivors Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: United States